DDI-CPI, a server that predicts drug-drug interactions through implementing the chemical-protein interactome

Nucleic Acids Research

Volumn 42, Issue W1, 2014, Pages

  Luo, Heng ^a,b,h   Zhang, Ping ^c   Huang, Hui ^a   Huang, Jialiang ^d   Kao, Emily ^e   Shi, Leming ^f   He, Lin ^a   Yang, Lun ^a,g  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c IBM T J WATSON RESEARCH CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e University of California at Berkeley   (United States)

^f FUDAN UNIVERSITY   (China)

^g GLAXOSMITHKLINE   (United States)

^h NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCARBOXAZID; LINEZOLID; NARATRIPTAN; SERTRALINE;

ACCURACY; ARTICLE; COMPARATIVE STUDY; CRYSTAL STRUCTURE; DATA ANALYSIS SOFTWARE; DRUG PROTEIN BINDING; MOLECULAR DOCKING; MOLECULAR LIBRARY; PREDICTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

RUMEX;

DRUG DESIGN; HUMANS; INTERNET; MOLECULAR DOCKING SIMULATION; PHARMACEUTICAL PREPARATIONS; PROTEINS; SERTRALINE; SOFTWARE;

EID: 84904806013     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku433     Document Type: Article

References (47)

1. Qato,D.M., Alexander,G.C., Conti,R.M., Johnson,M., Schumm,P. and Lindau,S.T. (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA, 300, 2867-2878.
2. Magnus,D., Rodgers,S. and Avery,A.J. (2002) GPs' views on computerized drug interaction alerts: questionnaire survey. J. Clin. Pharm. Ther., 27, 377-382.
3. Bjornsson,T.D., Callaghan,J.T., Einolf,H.J., Fischer,V., Gan,L., Grimm,S., Kao,J., King,S.P., Miwa,G., Ni,L. et al. (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab. Dispos., 31, 815-832.
4. Duke,J.D., Han,X., Wang,Z., Subhadarshini,A., Karnik,S.D., Li,X., Hall,S.D., Jin,Y., Callaghan,J.T., Overhage,M.J. et al. (2012) Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput. Biol., 8, e1002614.
5. Jia,J., Zhu,F., Ma,X., Cao,Z., Cao,Z.W., Li,Y., Li,Y.X. and Chen,Y.Z. (2009) Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov., 8, 111-128.
6. Beijnen,J.H. and Schellens,J.H. (2004) Drug interactions in oncology. Lancet Oncol., 5, 489-496.
7. Chen,Q., Zhang,T.,Wang,J.F. and Wei,D.Q. (2011) Advances in human cytochrome p450 and personalized medicine. Curr. Drug Metab., 12, 436-444.
8. Huang,J., Niu,C., Green,C.D., Yang,L., Mei,H. and Han,J.D. (2013) Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network. PLoS Comput. Biol., 9, e1002998.
9. Xie,L., Wang,J. and Bourne,P.E. (2007) In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators. PLoS Comput. Biol., 3, e217.
10. Xie,L., Li,J. and Bourne,P.E. (2009) Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput. Biol., 5, e1000387.
11. Gottlieb,A., Stein,G.Y., Oron,Y., Ruppin,E. and Sharan,R. (2012) INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol., 8, 592.
12. Rodrigues,A.D. and Lin,J.H. (2001) Screening of drug candidates for their drug-drug interaction potential. Curr. Opin. Chem. Biol., 5, 396-401.
13. Ekins,S. and Wrighton,S.A. (2001) Application of in silico approaches to predicting drug-drug interactions. J. Pharmacol. Toxicol. Methods, 45, 65-69.
14. Rekic,D., Roshammar,D., Mukonzo,J. and Ashton,M. (2011) In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype. Br. J. Clin. Pharmacol., 71, 536-543.
15. von Eichborn,J., Murgueitio,M.S., Dunkel,M., Koerner,S., Bourne,P.E. and Preissner,R. (2011) PROMISCUOUS: a database for network-based drug-repositioning. Nucleic Acids Res., 39, D1060-D1066.
16. Tatonetti,N.P., Fernald,G.H. and Altman,R.B. (2012) A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J. Am. Med. Inform. Assoc., 19, 79-85.
17. Vilar,S., Uriarte,E., Santana,L., Tatonetti,N.P. and Friedman,C. (2013) Detection of drug-drug interactions by modeling interaction profile fingerprints. PLoS One, 8, e58321.
18. Yang,L., Wang,K., Chen,J., Jegga,A.G., Luo,H., Shi,L., Wan,C., Guo,X., Qin,S., He,G. et al. (2011) Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome-clozapine-induced agranulocytosis as a case study. PLoS Comput. Biol., 7, e1002016.
19. Yang,L., Chen,J., Shi,L., Hudock,M.P., Wang,K. and He,L. (2010) Identifying unexpected therapeutic targets via chemical-protein interactome. PLoS One, 5, e9568.
20. Chen,Y.Z. and Zhi,D.G. (2001) Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins, 43, 217-226.
21. Li,H., Gao,Z., Kang,L., Zhang,H., Yang,K., Yu,K., Luo,X., Zhu,W., Chen,K., Shen,J. et al. (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res., 34, W219-W224.
22. Rognan,D. (2013) Proteome-scale docking: myth and reality. Drug Discov. Today Technol., 10, e403-e409.
23. Wallach,I., Jaitly,N. and Lilien,R. (2010) A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways. PLoS One, 5, e12063.
24. Yang,L., Chen,J. and He,L. (2009) Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome. PLoS Comput. Biol., 5, e1000441.
25. Yang,L., Luo,H., Chen,J., Xing,Q. and He,L. (2009) SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome. Nucleic Acids Res., 37, W406-W412.
26. Luo,H., Chen,J., Shi,L., Mikailov,M., Zhu,H., Wang,K., He,L. and Yang,L. (2011) DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res., 39, W492-W498.
27. Wishart,D.S., Knox,C., Guo,A.C., Shrivastava,S., Hassanali,M., Stothard,P., Chang,Z. and Woolsey,J. (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res., 34, D668-D672.
28. Kuhn,M., von Mering,C., Campillos,M., Jensen,L.J. and Bork,P. (2008) STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res., 36, D684-D688.
29. Pedretti,A., Villa,L. and Vistoli,G. (2004) VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J. Comput. Aided Mol. Des., 18, 167-173.
30. Berman,H.M.,Westbrook,J., Feng,Z., Gilliland,G., Bhat,T.N., Weissig,H., Shindyalov,I.N. and Bourne,P.E. (2000) Protein Data Bank. Nucleic Acids Res., 28, 235-242.
31. Yang,L., Price,E.T., Chang,C.W., Li,Y., Huang,Y., Guo,L.W., Guo,Y., Kaput,J., Shi,L. and Ning,B. (2013) Gene expression variability in human hepatic drug metabolizing enzymes and transporters. PLoS One, 8, e60368.
32. Wang,R., Fang,X., Lu,Y. andWang,S. (2004) The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J. Med. Chem., 47, 2977-2980.
33. Magrane,M. and Consortium,U. (2011) UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford), 2011, bar009.
34. Trott,O. and Olson,A.J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 31, 455-461.
35. Houston,D.R. and Walkinshaw,M.D. (2013) Consensus docking: improving the reliability of docking in a virtual screening context. J. Chem. Inf. Model., 53, 384-390.
36. O'Boyle,N.M., Banck,M., James,C.A., Morley,C., Vandermeersch,T. and Hutchison,G.R. (2011) Open Babel: an open chemical toolbox. J. Cheminform., 3, 33.
37. Morris,G.M., Huey,R., Lindstrom,W., Sanner,M.F., Belew,R.K., Goodsell,D.S. and Olson,A.J. (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem., 30, 2785-2791.
38. Harriman,D.J. and Deslongchamps,G. (2004) Reverse-docking as a computational tool for the study of asymmetric organocatalysis. J. Comput. Aided Mol. Des., 18, 303-308.
39. Campillos,M., Kuhn,M., Gavin,A.C., Jensen,L.J. and Bork,P. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
40. Fabre,L.F., Abuzzahab,F.S., Amin,M., Claghorn,J.L.,Mendels,J., Petrie,W.M., Dube,S. and Small,J.G. (1995) Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol. Psychiatry, 38, 592-602.
41. Wild,M.J., McKillop,D. and Butters,C.J. (1999) Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. Xenobiotica, 29, 847-857.
42. Narita,M., Tsuji,B.T. and Yu,V.L. (2007) Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy, 27, 1189-1197.
43. Brannan,S.K., Talley,B.J. and Bowden,C.L. (1994) Sertraline and isocarboxazid cause a serotonin syndrome. J. Clin. Psychopharmacol., 14, 144-145.
44. Sclar,D.A., Robison,L.M. and Skaer,T.L. (2008) Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome. Headache, 48, 126-129.
45. Shitara,Y., Itoh,T., Sato,H., Li,A.P. and Sugiyama,Y. (2003) Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J. Pharmacol. Exp. Ther., 304, 610-616.
46. Ohyama,K., Nakajima,M., Suzuki,M., Shimada,N., Yamazaki,H. and Yokoi,T. (2000) Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br. J. Clin. Pharmacol., 49, 244-253.
47. Takatsuka,Y., Chen,C. and Nikaido,H. (2010) Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A., 107, 6559-6565.